304 related articles for article (PubMed ID: 12211146)
1. DA agonists -- non-ergot derivatives: apomorphine: management of Parkinson's disease.
Mov Disord; 2002; 17 Suppl 4():S83-9. PubMed ID: 12211146
[No Abstract] [Full Text] [Related]
2. DA agonists -- ergot derivatives: lisuride: management of Parkinson's disease.
Mov Disord; 2002; 17 Suppl 4():S74-8. PubMed ID: 12211144
[No Abstract] [Full Text] [Related]
3. DA agonists -- non-ergot derivatives: pramipexole: management of Parkinson's disease.
Mov Disord; 2002; 17 Suppl 4():S93-7. PubMed ID: 12211148
[No Abstract] [Full Text] [Related]
4. DA agonists -- non-ergot derivatives: piribedil: management of Parkinson's disease.
Mov Disord; 2002; 17 Suppl 4():S90-2. PubMed ID: 12211147
[No Abstract] [Full Text] [Related]
5. DA agonists -- ergot derivatives: pergolide: management of Parkinson's disease.
Mov Disord; 2002; 17 Suppl 4():S79-82. PubMed ID: 12211145
[No Abstract] [Full Text] [Related]
6. Use of apomorphine in Parkinson's disease.
Stocchi F
Neurol Sci; 2008 Dec; 29 Suppl 5():S383-6. PubMed ID: 19381769
[TBL] [Abstract][Full Text] [Related]
7. DA agonists -- non-ergot derivatives: ropinirole: management of Parkinson's disease.
Mov Disord; 2002; 17 Suppl 4():S98-102. PubMed ID: 12211149
[No Abstract] [Full Text] [Related]
8. DA agonists -- ergot derivatives: dihydroergocryptine (DHEC): management of Parkinson's disease.
Mov Disord; 2002; 17 Suppl 4():S72-3. PubMed ID: 12211143
[No Abstract] [Full Text] [Related]
9. Adding a dopamine agonist to preexisting levodopa therapy vs. levodopa therapy alone in advanced Parkinson's disease: a meta analysis.
Talati R; Baker WL; Patel AA; Reinhart K; Coleman CI
Int J Clin Pract; 2009 Apr; 63(4):613-23. PubMed ID: 19222614
[TBL] [Abstract][Full Text] [Related]
10. DA agonists -- ergot derivatives: bromocriptine: management of Parkinson's disease.
Mov Disord; 2002; 17 Suppl 4():S53-67. PubMed ID: 12211141
[No Abstract] [Full Text] [Related]
11. A review of intermittent subcutaneous apomorphine injections for the rescue management of motor fluctuations associated with advanced Parkinson's disease.
Chen JJ; Obering C
Clin Ther; 2005 Nov; 27(11):1710-24. PubMed ID: 16368444
[TBL] [Abstract][Full Text] [Related]
12. Parkinson's disease.
Clarke C; Moore AP
Clin Evid; 2002 Jun; (7):1208-20. PubMed ID: 12230738
[No Abstract] [Full Text] [Related]
13. Dopamine agonists in the treatment of Parkinson's disease.
Bonuccelli U; Pavese N
Expert Rev Neurother; 2006 Jan; 6(1):81-9. PubMed ID: 16466315
[TBL] [Abstract][Full Text] [Related]
14. Continuous apomorphine infusion and neuropsychiatric disorders: a controlled study in patients with advanced Parkinson's disease.
Di Rosa AE; Epifanio A; Antonini A; Stocchi F; Martino G; Di Blasi L; Tetto A; Basile G; Imbesi D; La Spina P; Di Raimondo G; Morgante L
Neurol Sci; 2003 Oct; 24(3):174-5. PubMed ID: 14598073
[TBL] [Abstract][Full Text] [Related]
15. Apomorphine therapy in Parkinson's disease: a review.
Haq IU; Lewitt PA; Fernandez HH
Expert Opin Pharmacother; 2007 Nov; 8(16):2799-809. PubMed ID: 17956200
[TBL] [Abstract][Full Text] [Related]
16. Initial therapy for Parkinson's disease: levodopa vs. dopamine receptor agonists.
Kondo T
J Neurol; 2002 Sep; 249 Suppl 2():II25-9. PubMed ID: 12375060
[TBL] [Abstract][Full Text] [Related]
17. Use of apomorphine in clinical practice.
MacMahon DG
Adv Neurol; 1999; 80():529-33. PubMed ID: 10410767
[No Abstract] [Full Text] [Related]
18. Levodopa: management of Parkinson's disease.
Mov Disord; 2002; 17 Suppl 4():S23-37. PubMed ID: 12211137
[No Abstract] [Full Text] [Related]
19. [Subcutaneous continuous apomorphine infusion: treatment initiation and follow up].
Grandas FJ; Sesar-Ignacio Á
Rev Neurol; 2012; 55 Suppl 1():S21-4. PubMed ID: 23169229
[TBL] [Abstract][Full Text] [Related]
20. Dopamine agonists in the treatment of early Parkinson's disease: a meta-analysis.
Baker WL; Silver D; White CM; Kluger J; Aberle J; Patel AA; Coleman CI
Parkinsonism Relat Disord; 2009 May; 15(4):287-94. PubMed ID: 18774743
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]